Aoxing Pharmaceutical (AXN) Widens Q3 Loss to 6c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts AXN Hot Sheet
Join SI Premium – FREE
Aoxing Pharmaceutical Co., Inc. (NYSE: AXN) reported Q3 EPS of ($0.06), versus ($0.01) reported last year. Revenue for the quarter came in at $1.81 million, versus $1.63 million reported last year.
For earnings history and earnings-related data on Aoxing Pharmaceutical Co., Inc. (AXN) click here.
For earnings history and earnings-related data on Aoxing Pharmaceutical Co., Inc. (AXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades UWM Holdings Corp. (UWMC) to Neutral
- Premarket movers: Iren jumps on Anthropic deal, CCC surges on buyout talks
- FirstEnergy Corp. (FE) PT Lowered to $47 at Mizuho
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
